Company Overview

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

  • Name

    ResMed Inc.

  • CEO

    Mr. Michael J. Farrell BE, MBA, SM

  • Website

    www.resmed.com

  • Sector

    Health Care Equipment and Supplies

  • Year Founded

    1989

Profile

  • Market Cap

    $35.98B

  • EV

    $36.61B

  • Shares Out

    146.93M

  • Revenue

    $4,685.3M

  • Employees

    9,980

Margins

  • Gross

    57.38%

  • EBITDA

    32.73%

  • Operating

    29.54%

  • Pre-Tax

    27%

  • Net

    21.79%

  • FCF

    27.78%

Returns (5Yr Avg)

  • ROA

    13.6%

  • ROTA

    27.08%

  • ROE

    22.87%

  • ROCE

    22.34%

  • ROIC

    16.97%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $232.48

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $238.36M

  • Net Debt

    $635.57M

  • Debt/Equity

    0.18

  • EBIT/Interest

    27.84

Growth (CAGR)

  • Rev 3Yr

    13.59%

  • Rev 5Yr

    12.44%

  • Rev 10Yr

    11.66%

  • Dil EPS 3Yr

    28.78%

  • Dil EPS 5Yr

    19.84%

  • Dil EPS 10Yr

    11.22%

  • Rev Fwd 2Yr

    7.32%

  • EBITDA Fwd 2Yr

    10.85%

  • EPS Fwd 2Yr

    13.58%

  • EPS LT Growth Est

    14.19%

Dividends

  • Yield

  • Payout

    27.65%

  • DPS

    $1.92

  • DPS Growth 3Yr

    6.49%

  • DPS Growth 5Yr

    5.06%

  • DPS Growth 10Yr

    6.74%

  • DPS Growth Fwd 2Yr

    9.72%

NYSE:RMD